🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21442Original Research

Bibliometric analysis of research hotspots on mitochondria and spinal cord injury treatment

Wang Lei¹,Hu Baoyang¹,Fang Fang¹

Tongliao Clinical Medical College, Inner Mongolia Medical University, Tongliao 028000, Inner Mongolia Autonomous Region, China

Read Executive PreviewQuick FAQ
Bibliometric analysis of research hotspots on mitochondria and spinal cord injury treatment
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1902, Issue 30 • pp. 100-112Citation:Wang Lei et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • A total of 558 publications on mitochondria and spinal cord injury treatment were analyzed, revealing a steady increase in research output from 1990 to 2024. • The United States and China are leading contributors in this field, with high publication counts, citation frequencies, and influential research institutions. • Current research hotspots focus on apoptosis and oxidative stress, while future directions may explore molecular mechanisms, inflammation, and neural repair. • Despite progress, the field faces challenges including limited high-quality literature and regional disparities in research development.
Sponsored Research Highlight

Abstract

BACKGROUND: Mitochondria are vital for axonal regeneration and apoptosis following spinal cord injury, making them an essential area of therapeutic research for this condition. OBJECTIVE: To summarize literature on mitochondria and spinal cord injury treatment, using bibliometric methods to elucidate the current research landscape, global trends, and comprehensive academic understanding in this field. METHODS: We retrieved relevant literature published between 1990 and 2024 from the Web of Science Core Collection database on topics related to mitochondria and the treatment of spinal cord injury. Visual analysis was conducted using CiteSpace 5.8 and VOS Viewer 1.6.18 software to draw knowledge maps and examine metrics such as publications, centrality, and H-index. Keyword analysis, co-cited journal analysis, co-cited document analysis, highly co-cited document analysis, and publication burst analysis were conducted to identify research hotspots and directions within the field. RESULTS AND CONCLUSION: A total of 558 publications were included in this bibliometric analysis, involving 48 countries, 3,036 authors, 713 institutions, and 252 journals. The number of publications in the field of mitochondria and spinal cord injury treatment has shown an increasing trend year by year. The United States and China have performed prominently in this field, ranking among the top globally in terms of publication output, citation frequency, core authors, and research institutions. Currently, research hotspots in this field focus on apoptosis and oxidative stress. Future research directions may center on molecular mechanisms, inflammatory responses, and neural repair. The field of mitochondria and spinal cord injury treatment holds great promise, with steady improvement in overall research level in recent years, but still faces challenges such as limited high-quality literature and significant regional disparities in research progress, which require further efforts by researchers.

1. Introduction

The spinal cord is a part of the central nervous system, containing nerves that receive sensory information and control motor responses. Spinal cord injury (SCI), as a severe central nervous system injury, leads to loss of sensory, motor, and autonomic nervous system functions below the level of injury [1-5]. SCI is a complex pathophysiological process, including primary and secondary injuries. Primary injury is usually unpredictable and almost impossible to intervene, so researchers focus on secondary injury. Currently, there are various improvement strategies for SCI, including surgical treatment, drug therapy, cell transplantation, and nanotechnology [6-9], but effective treatment options are still lacking. To address this challenge, researchers are actively exploring innovative experimental and therapeutic approaches.

Mitochondria are key organelles in cells, present in almost all cells except red blood cells, and perform multiple important functions, including promoting ATP and reactive oxygen species generation, storing calcium ions, and participating in the regulation of programmed cell death, controlling cell survival [10-11]. After SCI, secondary injury causes mitochondrial dysfunction, disrupting oxidative phosphorylation, significantly reducing energy release and ATP production efficiency, and inactivating ATP-dependent ion pumps required for regulating ion concentrations and uptake of the excitatory neurotransmitter glutamate. This dysfunction ultimately triggers excitotoxicity, calcium overload, and initiates cell death cascades, leading to apoptosis [12-14]. Improving mitochondrial function for SCI recovery is not a single intervention but a multidimensional approach that blocks cell death cascades, protects existing cells, regulates immunometabolism to promote inflammation resolution, repairs neural structures, and replenishes functional cells, enhancing local neural structure and functional reconstruction, and facilitating motor and sensory recovery, thereby breaking the vicious cycle after SCI.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Wang Lei, Hu Baoyang, Fang Fang (2026). Bibliometric analysis of research hotspots on mitochondria and spinal cord injury treatment. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21442
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the main objective of this bibliometric analysis?

The main objective is to summarize the literature on mitochondria and spinal cord injury treatment using bibliometric methods, to understand the current research landscape, global trends, and comprehensive academic understanding in this field.

Which databases and tools were used in this study?

The study used the Web of Science Core Collection database as the data source, and CiteSpace 5.8 and VOS Viewer 1.6.18 software for visual analysis.

How many publications were included in the analysis?

A total of 558 publications were included in the bibliometric analysis.

What are the current research hotspots in this field?

Current research hotspots focus on apoptosis and oxidative stress, with future directions potentially exploring molecular mechanisms, inflammation, and neural repair.

Which countries are leading in this research area?

The United States and China are leading contributors, with high publication counts, citation frequencies, and influential research institutions.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF